Suppr超能文献

基于DNA的植物药和植物源膳食补充剂认证:我们从何而来,又将何去?

DNA-Based Authentication of Botanicals and Plant-Derived Dietary Supplements: Where Have We Been and Where Are We Going?

作者信息

Coutinho Moraes Denise F, Still David W, Lum Michelle R, Hirsch Ann M

机构信息

Federal University of Maranhão (UFMA), Department of Pharmacy, São Luis, Maranhão, Brazil.

Department of Plant Science, California State Polytechnic University, Pomona, CA, USA.

出版信息

Planta Med. 2015 Jun;81(9):687-95. doi: 10.1055/s-0035-1545843. Epub 2015 Apr 9.

Abstract

Herbal medicines and botanicals have long been used as sole or additional medical aids worldwide. Currently, billions of dollars are spent on botanicals and related products, but minimal regulation exists regarding their purity, integrity, and efficacy. Cases of adulteration and contamination have led to severe illness and even death in some cases. Identifying the plant material in botanicals and phytomedicines using organoleptic means or through microscopic observation of plant parts is not trivial, and plants are often misidentified. Recently, DNA-based methods have been applied to these products because DNA is not changed by growth conditions unlike the chemical constituents of many active pharmaceutical agents. In recent years, DNA barcoding methods, which are used to identify species diversity in the Tree of Life, have been also applied to botanicals and plant-derived dietary supplements. In this review, we recount the history of DNA-based methods for identification of botanicals and discuss some of the difficulties in defining a specific bar code or codes to use. In addition, we describe how next generation sequencing technologies have enabled new techniques that can be applied to identifying these products with greater authority and resolution. Lastly, we present case histories where dietary supplements, decoctions, and other products have been shown to contain materials other than the main ingredient stipulated on the label. We conclude that there is a fundamental need for greater quality control in this industry, which if not self-imposed, that may result from legislation.

摘要

草药和植物药长期以来在全球范围内被用作唯一的或辅助的医疗手段。目前,人们在植物药及相关产品上花费了数十亿美元,但对于其纯度、完整性和功效的监管却微乎其微。掺假和污染事件在某些情况下导致了严重疾病甚至死亡。通过感官手段或对植物部分进行显微镜观察来鉴定植物药和植物医学中的植物材料并非易事,植物常常被误认。最近,基于DNA的方法已应用于这些产品,因为与许多活性药物成分不同,DNA不会因生长条件而改变。近年来,用于识别生命之树中物种多样性的DNA条形码方法也已应用于植物药和植物源膳食补充剂。在本综述中,我们讲述了基于DNA的植物药鉴定方法的历史,并讨论了定义一个或多个特定条形码时遇到的一些困难。此外,我们描述了新一代测序技术如何催生了能够以更高的权威性和分辨率应用于识别这些产品的新技术。最后,我们列举了膳食补充剂、汤剂和其他产品被证明含有标签上规定的主要成分以外的物质的案例。我们得出结论,该行业迫切需要加强质量控制,若行业自身不加以实施,可能会通过立法来实现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验